SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 2 filers reported holding SUTRO BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,615 | +11.5% | 27,771 | +43.1% | 0.00% | – |
| Q1 2023 | $87,539 | -37.2% | 19,410 | +8.1% | 0.00% | – |
| Q4 2022 | $139,350 | +76.4% | 17,958 | +27.1% | 0.00% | – |
| Q3 2022 | $79,000 | +19.7% | 14,134 | +12.6% | 0.00% | – |
| Q2 2022 | $66,000 | -60.0% | 12,557 | -22.2% | 0.00% | – |
| Q3 2020 | $165,000 | +1.2% | 16,143 | -10.1% | 0.00% | – |
| Q3 2019 | $163,000 | – | 17,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |